DOT Drug Testing New Rochelle, NY

Our Local DOT Drug testing facilities in New Rochelle, NY and the surrounding areas provide DOT Drug Testing, DOT Alcohol Testing, DOT Physicals, Consortium enrollment and other DOT services for Employers, Single operators and all DOT modes who are required to comply with 49 CFR Part 40 in New Rochelle, NY including FMCSA, FTA, FAA, USCG, FRA and PHMSA . Testing centers are within minutes of your home or office and same day service is available in most cases.

"When you need a test, choose the best"

(800) 221-4291

Schedule Your Test

How to schedule a DOT drug test in New Rochelle, NY

To schedule any type of DOT drug test or alcohol test in New Rochelle, NY call our local scheduling department at (800) 221-4291. You may also schedule your DOT drug test online utilizing our express scheduling registration system by selecting your test and completing the Donor Information/Registration Section. You must register for the test prior to proceeding to the testing center.

The zip code you enter will be used to determine the closest DOT drug or DOT alcohol testing center which performs the type of test you have selected. A donor pass/registration form with the local testing center address, hours of operation and instructions will be sent to the e-mail address you provided. Take this form with you or have it available on your smart phone to provide to the testing center. No appointment is necessary in most cases. However, you must complete the donor information section and pay for the test at the time of registration.

Our laboratories are SAMHSA certified and all test results are verified by our in-house licensed physicians who serve as Medical Review Officers (MRO).

In addition to providing DOT drug testing and DOT breath alcohol testing in New Rochelle, NY, Accredited Drug Testing also has additional testing centers throughout the metropolitan area and surrounding cities.

On the road or on vacation, no worries, Accredited Drug Testing has over 20,000 testing centers in all cities Nationwide and we can schedule your test, ANYWHERE, ANYTIME!

(800) 221-4291

Schedule Your Test

What are the DOT drug testing requirements?

In 1991, the Omnibus Transportation Employee Testing Act created the following DOT Agencies which established drug and alcohol testing regulations to ensure that aircraft, trains, trucks, and buses were operated in a safe and responsible manner. As an employer or individual operating in a "Safety Sensitive" position, it is important to understand how these regulations impact you.

49 CFR Part 40 (commonly known as "part 40") explains:

• How drug and alcohol testing is conducted
• Who is authorized to participate in the drug and alcohol testing program
• What employees must do before they may return to duty after a drug and/or alcohol violation

Each DOT Agency and the USCG have specific regulations that cover:

• The agency's prohibitions on drug and alcohol use
• Who is subject to comply with these regulations
• What type of testing is required
• When testing is required
• Consequences of non-compliance

FMCSA Drug and Alcohol Clearinghouse

The Federal Motor Carrier Safety Administration (FMCSA) amended its rule that would establish requirements for commercial driver's license employers and individuals with regards to the drug and alcohol clearing house which will take affect on January 6, 2020.

The FMCSA Clearinghouse is a secure online database that will allow employers, the FMCSA, State Driver Licensing Agencies, State Law Enforcement and individual CDL operators to access real time important information about a CDL Driver's drug and alcohol program violations and the ultimate goal of this database is to enhance safety on our Nation's public roadways.

For specific requirements, click the appropriate agency listed below in which you or your company is regulated by. Ask about our DOT Complete Compliance Package!

• Federal Aviation Administration (FAA) (14 CFR Part 120)
• United States Coast Guard (USCG) (46 CFR Parts 4,5 and 16)
• Federal Motor Carrier Safety Administration (FMCSA) (49 CFR Part 382)
• Pipeline and Hazardous Materials Safety Administration (PHMSA) (49 CFR Part 199)
• Federal Transit Administration (FTA) (49 CFR Part 655)
• Federal Railroad Administration (FRA) (49 CFR Part 219)

The Opioid Overdose Crisis

Every day, more than 130 people in the United States die after overdosing on opioids. The misuse of and addiction to opioids, including prescription pain relievers, heroin, and synthetic opioids such as fentanyl, is a serious national crisis that affects public health as well as social and economic welfare. The Centers for Disease Control and Prevention estimates that the total "economic burden" of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.

• Roughly 21 to 29 percent of patients prescribed opioids for chronic pain misuse them.
• Between 8 and 12 percent develop an opioid use disorder.
• An estimated 4 to 6 percent who misuse prescription opioids transition to heroin.
• About 80 percent of people who use heroin first misused prescription opioids.
• Opioid overdoses increased 30 percent from July 2016 through September 2017 in 52 areas in 45 states.
• The Midwestern region saw opioid overdoses increase 70 percent from July 2016 through September 2017.
• Opioid overdoses in large cities increase by 54 percent in 16 states.

In the late 1990s, pharmaceutical companies reassured the medical community that patients would not become addicted to prescription opioid pain relievers, and healthcare providers began to prescribe them at greater rates. This subsequently led to widespread diversion and misuse of these medications before it became clear that these medications could indeed be highly addictive.3,4 Opioid overdose rates began to increase. In 2017, more than 47,000 Americans died as a result of an opioid overdose, including prescription opioids, heroin, and illicitly manufactured fentanyl, a powerful synthetic opioid.1That same year, an estimated 1.7 million people in the United States suffered from substance use disorders related to prescription opioid pain relievers, and 652,000 suffered from a heroin use disorder (not mutually exclusive)

DOT Compliance Checklist in New Rochelle, NY

DOT 49 CFR Part 40 Requirements for Safety Sensitive Employees.
(FMCSA-FAA-USCG-FRA-PHMSA-FTA)